fda warning letters glp-1 november 2025 issued a letter to a medical spa for failing to follow requirements that help ensure prescription drugs are safe and come from verified sources. These safeguards protect patients from potentially FDA Sends Warning Letters to
Description
Switch to glycinate, citrate, or any other form with better absorption
In the study published by the Jama Network (linked above), it was found that individuals who use GLP-1 drugs have a 9.09 times higher risk of developing pancreatitis
This prevents both forgetting and accidental early dosing
Earlier this year, Ro launched the GLP-1 Supply Tracker, an open-access tool set up to help patients and providers keep track of which GLP-1 medications are in stock and which are in shortage
